RenovoRx, Inc. - Common Stock (NQ:RNXT)

1.485 -0.095 (-6.01%)

Delayed Quote Updated: 3:40 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about RenovoRx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 23, 2023

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 444.4% to $1.47 after the company announced it successfully completed the review of results from Milestone 7, a phase of its...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 23, 2023

Via Benzinga

Dow Falls 200 Points; Jobless Claims Drop To 4-Month Low ↗

January 19, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping around 200 points on Thursday.

Via Benzinga

RenovoRx Reports Initial Results From Targeted Treatment For Pancreatic Cancer ↗

January 18, 2023

Via Benzinga

Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 19, 2023

Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 19, 2023

Via Benzinga

Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 18, 2023

Gainers Ontrak, Inc. (NASDAQ: OTRK) shares jumped 101.7% to $1.1599 after the company announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+...

Via Benzinga

RenovoRx Announces Initial Results in Pharmacokinetic (PK) Substudy: Data on RenovoGem™ Supports Potential for RenovoTAMP® Therapy Platform to Increase Local Gemcitabine (Chemotherapy) Delivery and Decrease Side Effects of Pancreatic Cancer Treatment

January 18, 2023

From RenovoRx, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 18, 2023

Via Benzinga

RenovoRx Strengthens Intellectual Property (IP) Portfolio with Eighth US Patent

January 05, 2023

From RenovoRx, Inc.

Via Business Wire

Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket ↗

December 16, 2022

Gainers Minim, Inc. (NASDAQ: MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

December 16, 2022

We're starting off the final trading day this week with a look at the biggest pre-market stock movers to watch for Friday!

Via InvestorPlace

RenovoRx Announces Acceptance of Four Clinical Data Abstracts at the 2023 ASCO Gastrointestinal Cancers (ASCO GI) Symposium

December 15, 2022

From RenovoRx, Inc.

Via Business Wire

RenovoRx Announces Presentations at the Advanced Interventional Management Symposium (AIMsymposium) Highlighting its Innovative RenovoTAMP® Therapy Platform for Targeted Treatment of Cancers

November 17, 2022

From RenovoRx, Inc.

Via Business Wire

RenovoRx Reports Third Quarter 2022 Financial Results

November 14, 2022

From RenovoRx, Inc.

Via Business Wire

RenovoRx to Participate in ROTH Capital Deep Dive Webinar on October 27, 2022 at 1:00 P.M. ET

October 21, 2022

From RenovoRx, Inc.

Via Business Wire

RenovoRx to Participate in Upcoming October 2022 Investor Conferences

October 04, 2022

From RenovoRx, Inc.

Via Business Wire

RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology (CIO) Highlighting its Innovative Therapy Platform for Targeted Treatment of Pancreatic Cancer

September 28, 2022

From RenovoRx, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 23, 2022

Gainers

Via Benzinga

RenovoRx Appoints Angela Gill Nelms as Chief Operating Officer

September 19, 2022

From RenovoRx, Inc.

Via Business Wire

Why LAVA Therapeutics Shares Are Trading Higher By 97%, Here Are 49 Stocks Moving In Monday's Mid-Day Session ↗

September 26, 2022

Gainers

Via Benzinga

RenovoRx to Participate in the H.C. Wainwright 24th Annual Global Investment Conference, September 12-14, 2022

September 07, 2022

From RenovoRx, Inc.

Via Business Wire

Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday ↗

September 26, 2022

Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.

Via Benzinga

Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session ↗

September 15, 2022

Gainers HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome...

Via Benzinga

RenovoRx Reports Second Quarter 2022 Financial Results

August 15, 2022

From RenovoRx, Inc.

Via Business Wire

Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday ↗

September 12, 2022

Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 09, 2022

Via Benzinga

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗

August 10, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Via Benzinga

RenovoRx Appoints James Ahlers as Chief Financial Officer

July 19, 2022

From RenovoRx, Inc.

Via Business Wire

RenovoRx Launches “The RenovoRx Story” Video Series

July 13, 2022

From RenovoRx, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.